The ability to refine prognoses on the basis of clinical parameters has been largely maximized. With the possible exception of dynamic determination of marker decline, it is unlikely that readily available clinical data will contribute significantly to newer or better prognostic systems. The advent of molecular oncology and the ability to perform biologic assessments of these fascinating tumors open the door to investigations of markers of proliferation, apoptosis, and gene expression as newer, more precise, and more therapeutically relevant end points. The same large cooperative efforts that led to the IGCCC system with clinical parameters may be required to validate these unfolding biologic parameters.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.